Literature DB >> 32499032

Asthma Across the Ages: Adults.

Paula J Busse1, Vanessa M McDonald2, Juan P Wisnivesky3, Peter G Gibson2.   

Abstract

Asthma is a common disease affecting approximately 300 million people worldwide, across all age ranges. Despite advances in asthma outcomes of the last few decades, there remains room for improvement in asthma management and for patient outcomes, particularly in older patients. The heterogeneity of asthma is now well recognized, and is known to complicate response to treatment and patient behavior and impact health outcomes. Asthma and its heterogeneity change according to age. Asthma affects people differently across the life span. In adults, prevalence is highest among those in middle age; however, mortality is greater in the older age group. In this clinical commentary, we describe how age impacts asthma prevalence and incidence, outcomes, disease expression, and approach to management in adulthood and in older patients.
Copyright © 2020. Published by Elsevier Inc.

Entities:  

Keywords:  Aging; Asthma; Management

Mesh:

Year:  2020        PMID: 32499032     DOI: 10.1016/j.jaip.2020.03.044

Source DB:  PubMed          Journal:  J Allergy Clin Immunol Pract


  6 in total

Review 1.  Advances and applications of monoolein as a novel nanomaterial in mitigating chronic lung diseases.

Authors:  Yinghan Chan; Sachin Kumar Singh; Monica Gulati; Sheetu Wadhwa; Parteek Prasher; Deepak Kumar; Avvaru Praveen Kumar; Gaurav Gupta; Gowthamarajan Kuppusamy; Mehra Haghi; Brian Gregory George Oliver; Jon Adams; Dinesh Kumar Chellappan; Kamal Dua
Journal:  J Drug Deliv Sci Technol       Date:  2022-06-23       Impact factor: 5.062

2.  Downregulation of DUOX1 function contributes to aging-related impairment of innate airway injury responses and accelerated senile emphysema.

Authors:  Caspar Schiffers; Lennart K A Lundblad; Milena Hristova; Aida Habibovic; Christopher M Dustin; Nirav Daphtary; Minara Aliyeva; David J Seward; Yvonne M W Janssen-Heininger; Emiel F M Wouters; Niki L Reynaert; Albert van der Vliet
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2021-05-05       Impact factor: 6.011

3.  Sarcopenia, systemic immune-inflammation index and all-cause mortality in middle-aged and older people with COPD and asthma: a population-based study.

Authors:  Elizabeth Benz; Sara R A Wijnant; Katerina Trajanoska; Johnmary T Arinze; Emmely W de Roos; Maria de Ridder; Ross Williams; Frank van Rooij; Katia M C Verhamme; M Arfan Ikram; Bruno H Stricker; Fernando Rivadeneira; Lies Lahousse; Guy G Brusselle
Journal:  ERJ Open Res       Date:  2022-01-10

4.  Investigating the Outcomes of an Asthma Educational Program and Useful Influence in Public Policy.

Authors:  Hamad Ghaleb Dailah
Journal:  Front Public Health       Date:  2021-11-26

Review 5.  Aging Immune System and Its Correlation With Liability to Severe Lung Complications.

Authors:  Yongtao Li; Chengfei Wang; Meilian Peng
Journal:  Front Public Health       Date:  2021-11-23

6.  Is overreliance on short-acting β2-agonists associated with health risks in the older asthma population?

Authors:  Teresa To; Jingqin Zhu; Emilie Terebessy; Kimball Zhang; Andrea S Gershon; Christopher Licskai
Journal:  ERJ Open Res       Date:  2022-03-28
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.